Study: Diabetes Pill Prevents Type 2 in 72 Percent of Participants
March 25, 2011 9:15 AM
In addition, 31 percent experienced a reduced rate of thickening of the carotid artery, which is a vessel that supplies blood to the brain
Researchers from the
University of Texas Health Science Center at San Antonio
and seven other collaborating centers have led a trial that demonstrates a pill that prevents type 2 diabetes in those high at risk.
Ralph DeFronzo, M.D., study leader and professor in the School of Medicine and chief of the diabetes division at the University of Texas Health Science Center in San Antonio, along with Robert Henry, M.D., president of the American Diabetes Association, have conducted a trial to show a pill that is capable of
preventing type 2 diabetes
in people who are high at risk due to
or their ethnicity and other markers. Type 2 diabetes is caused by abnormalities associated with insulin, which is secreted by beta cells in the pancreas. The body is insulin resistant when type 2 diabetes is present, meaning that the body is unable to store and use sugar from food and beta cells begin to die as time goes by. Currently, 40 million Americans are pre-diabetic.
The pill is called pioglitazone, and it is marketed as Actos® by Takeda Pharmaceutical Co. Ltd., which gave DeFronzo an independent investigator grant in order to conduct the study. Pioglitazone is an insulin sensitizer for those with type 2 diabetes, which works by stimulating appetite and shifting fat from from the liver, muscles, and beta cells into subcutaneous "fat depots" under the skin where it is not harmful.
The study, which was called
the ACT Now study
, consisted of 602 test subjects that had a high risk of developing type 2 diabetes. They were instructed to take the pill once a day in the morning.
According to results, 72 percent of participants benefitted from the pill and did not develop type 2 diabetes. In addition, 31 percent experienced a reduced rate of thickening of the carotid artery, which is a vessel that supplies blood to the brain.
"It's a blockbuster study," said DeFronzo. "The 72 reduction is the largest decrease in the conversion rate of pre-diabetes to diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication."
According to Robert Chilton, D.O., FACC, a University of Texas Health Science Center San Antonio cardiologist, the pill controlled participants' glucose and prevented blood vessel damage that can cause
The side effects of pioglitazone are weight gain and fluid retention, but DeFronzo said these can be avoided by taking lower doses. He has admitted that the drug hasn't been perfected quite yet, but it improves insulin resistance and beta cell function, which makes the pill an excellent first step to treating and preventing diabetes successfully.
"The drug shows outstanding results," said Henry. "It is the most efficacious method we have studied to date to delay or prevent the onset of type 2 diabetes."
was published in
The New England Journal of Medicine
"We basically took a look at this situation and said, this is bullshit." -- Newegg Chief Legal Officer Lee Cheng's take on patent troll Soverain
Growth Hormone Deficiency May Prevent Diabetes, Cancer
February 18, 2011, 6:24 AM
World Has Grown Much, Much Fatter: Obesity Doubles in 30 Years
February 4, 2011, 11:03 AM
New Microthread Technology Could Deliver Stem Cells Directly to Damaged Hearts
December 10, 2010, 9:45 AM
PIQ ROBOTTM reveals its new artificial intelligence software
November 29, 2016, 12:59 AM
One more time - Happy Thanksgiving to Everyone Around the World
November 24, 2016, 4:00 AM
Google’s Smart Contact Lens Project gets halted for 2016
November 20, 2016, 7:00 AM
Cell Research Study shows African Americans have greater immune response to infection
November 10, 2016, 1:00 AM
UTHealth Clinical Trial Shows Progress Using Stem Cells to Treat Traumatic Brain Injury
November 8, 2016, 1:00 AM
Uber Partners with Circulation to Pilot Program Connecting Transportation and Digital Health Care
November 6, 2016, 5:00 AM
Most Popular Articles
What Can You Do with Your New Echo Dot?
December 3, 2016, 5:00 AM
Google has developed Deep Learning Algorithm to detect Diabetic Eye Disease
December 4, 2016, 5:00 AM
Microsoft Surface – Which Surface is Right for You?
December 2, 2016, 5:00 AM
The iPlugmate is an Excellent iPhone Flash Drive at a Great Price. (Deal Expires in 3 Days)
November 23, 2016, 1:00 AM
Foscam R2 Home Security Camera System – High Quality High FHD Security Video Footage with No Monthly Fees
December 1, 2016, 2:00 AM
Latest Blog Posts
Latest Tech News
Dec 8, 2016, 5:11 AM
In The News
Dec 7, 2016, 5:00 AM
e Guide: Mobile Security for 2017
Dec 6, 2016, 5:00 AM
Apple Car is Not Dead
Dec 5, 2016, 1:00 AM
Dec 4, 2016, 5:00 AM
Dec 3, 2016, 5:00 AM
Dec 2, 2016, 5:00 AM
Surface Ergonomic Keyboard
Dec 1, 2016, 3:01 AM
Chapeconense plane crash: Football rallies around Brazilian Team
Nov 30, 2016, 1:00 AM
How to Extends Your iPhone’s Battery Life
Nov 29, 2016, 12:49 AM
Nov 28, 2016, 1:12 AM
News: Fidel Castro
Nov 27, 2016, 5:00 AM
Nov 26, 2016, 5:00 AM
Changes in Social status affect the way genes turn on and off within immune cells.
Nov 25, 2016, 5:12 AM
Austrian far–right hopeful Hofer may back EU vote.
Nov 24, 2016, 4:00 AM
Final Fantasy XV Leaked Before Nov 29 Launch Date
Nov 23, 2016, 1:00 AM
Nov 22, 2016, 2:26 AM
Nov 21, 2016, 1:00 AM
HTC Makes Big Moves in China
Nov 20, 2016, 2:00 AM
Do you know who is the number one company in the word?
Nov 19, 2016, 5:30 AM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information